Recent studies have investigated the epigenetic effects of environmental exposure to chemicals on human health. The associations of DNA methylation, environmental exposure and human diseases have been widely demonstrated. However, the use of gene methylation patterns as a predictive biomarker for exposure to environmental toxicants is relatively poorly understood. Here, we focused on low-molecular-weight saturated aliphatic aldehydes (LSAAs), which are important environmental risk factors in humans as major indoor air pollutants. Based on DNA methylation profiling in gene promoter regions, we analysed DNA methylation profiles following exposure of A549 cells to seven LSAAs (propanal, butanal, pentanal, hexanal, heptanal, octanal, and nonanal) to identify LSAAcharacterized methylated sites and target genes, as well as to investigate whether exposure to LSAAs contributes to inducing of pulmonary toxicity. Additionally, by integrating DNA methylation and mRNA expression profile analyses, we identified core anti-correlated target genes. Gene ontology analysis of these target genes revealed several key biological processes. These findings suggest that alterations in DNA methylation by exposure to LSAAs provide novel epigenetic biomarkers for risk assessments. This DNA methylation-mRNA approach also reveals potential new mechanistic insights into the epigenetic actions of pulmonary toxicity.
aliphatic aldehydes (LSAAs) for DNA methylome analysis. In previous studies, we investigated the genetic and epigenetic responses of LSAAs based on transcriptome and microRNA analyses 8, 9 . Here, we performed epigenome-wide DNA methylome analysis in aldehyde-exposed A549 lung adenocarcinoma cells.
Aldehydes are categorized as volatile organic compounds, which are ubiquitous in indoor and outdoor air as common air pollutants 10 . They are emitted from diverse indoor sources such as carpets, floor coverings, paints, panels, and furniture 11 . Recognition of the health effects of indoor air pollutants has also increased. Although studies on the pulmonary effect of aldehydes have been conducted 12 , the data remain limited for several aldehydes such as formaldehyde and acetaldehyde. In this study, we investigated the pulmonary toxic effects of LSAAs including propanal, butanal, pentanal, hexanal, heptanal, octanal, and nonanal. To investigate the epigenetic DNA methylation biomarkers of aldehydes on the human respiratory system for health risk assessment, we performed DNA methylome analysis. Following DNA methylation profiling, we performed integrated analyses of the methylation and mRNA data in A549 cells exposed to aldehydes to identify correlations.
Taken together, these findings indicate the potential pulmonary toxic effects of aldehyde exposure. Such DNA methylation biomarkers also improve the understanding of the underlying mechanisms of epigenetic regulation associated with aldehyde exposure.
Results
Cytotoxicity of A549 cells exposed to aldehydes. To determine the optimal exposure concentrations, the cytotoxicities of seven aldehydes were evaluated in the MTT assay ( Fig. S1 ). Based on the MTT assay data, the cell viability inhibitory concentrations (IC) of each aldehyde at 20% (IC 20 ) were calculated and compared to those of the dimethyl sulfoxide (DMSO) vehicle control group. Each inhibitory concentration of the seven aldehydes is shown in Table 1 .
DNA methylation signatures following exposure to the seven aldehydes. To investigate the genome-wide promoter DNA methylation expression profiles in A549 cells exposed to aldehydes, we performed a human 2 × 400 k DNA methylation microarray (Agilent Technologies, Santa Clara, CA, USA). The 414,043 methylation probes resulted in the DNA methylation of A549 cells based on unsupervised hierarchical clustering analysis. We identified the total DNA methylation expression patterns in A549 cells exposed to the aldehydes (Fig. 1) , and then examined the overall DNA methylation levels to identify aldehyde-specific epigenetic DNA methylation markers. 
Identification of characteristic aldehydes methylation markers.
To determine whether exposure to aldehydes alters DNA methylation, we conducted DNA methylome analysis of seven aldehydes (C3-C9) using an in vitro model. First, we isolated methylated DNA using MeDIP from genomic DNA. Using this methylated DNA, a DNA methylation profile was acquired and analysed in the group exposed to the seven aldehydes and matched vehicle control group (Fig. 2 , Table 2 ). In the propanal (C3) exposure group, we identified 4,345 genes that were differentially methylated (hyper-: 3,115 and hypo-: 1,230). In the butanal (C4) exposure group, 4,316 differentially methylated genes (hyper-: 1,584 and hypo-: 2,732) were identified. In the pentanal (C5) exposure group, 4,266 methylated genes (hyper-: 2,304 and hypo-: 1,962) were identified and 4,712 genes (hyper-: 1,572 and hypo-: 3,140) were methylated by hexanal (C6) exposure, and 3,598 target genes (hyper-: 897 and hypo-: 2,701) were identified following heptanal (C7) exposure. In the octanal (C8) exposure group, 3,822 methylated genes (hyper-: 1,611 and hypo-: 2,211) were identified, and 4,468 genes (hyper-: 1,898 and hypo-: 2,570) were methylated by nonanal (C9) exposure. Among them, 54 genes showed common methylated expression patterns in the seven aldehydes exposure group ( Fig. 3 , Table 3 ). All methylated genes showed significant changes of 3.0-fold with p-values < 0.05.
Integrated analysis of methylated DNA and mRNA expression profiles.
We also conducted integrated analysis of DNA methylation and mRNA expression. First, we conducted gene expression profiling of cells exposed to the seven aldehydes to identify differentially expressed genes (Fig. 4) . The differentially expressed genes in the A549 cells exposed to aldehydes were detected using the Human Whole Genome Microarray 44 K array (GSE56005). Next, we performed an integrative analysis of DNA methylation and mRNA expression to investigate whether DNA methylation has a regulatory impact on gene expression following aldehyde exposure. We identified hyper-methylated and down-regulated genes and hypo-methylated and up-regulated ones in each of aldehyde exposure groups (Table 4 ). These genes were considered potential epigenetic biomarkers for determining the exposure of the LSAAs.
GO and KEGG pathway analyses of candidate DNA methylation biomarkers of aldehydes.
To investigate the related biological process and pathway of aldehyde-specific methylated genes, we performed GO and KEGG pathway analyses using DAVID bioinformatics resources. We analysed each aldehyde-matched DNA methylated genes. The common key biological processes were mainly involved in cell surface receptor linked signal transductions (GO:0007166) such as the G-protein coupled receptor (GPCR) signalling pathway (GO:0007186) and neurological system process (GO:0050877). KEGG pathway analysis revealed that aldehyde exposure was associated with neuroactive ligand-receptor interaction, calcium signalling pathway, and pathways in cancer. Although we identified overlapping similar biological processes and pathways for seven aldehydes, each aldehyde has distinct biological functions (Tables 5 and 6 ). 
Discussion
Saturated aliphatic aldehydes are widely used in perfumes, essential oils, and flavoring 13 . They are also considered as indoor and outdoor air pollutants 14 . Human exposure to aldehydes occurs mainly by inhalation. Therefore, several studies have monitored the levels of aldehydes in the environment and reported the potential adverse health effects on humans 15 . Additionally, previous studies demonstrated that aldehydes may contribute to the development of various disease including pulmonary inflammatory diseases such as tracheitis, bronchitis, and bronchiolitis 16 . Among the aldehydes, formaldehyde and acetaldehyde are the most widely studied in compaison with other aldehydes. Little information is available regarding the toxicity of the other aldehydes, although numerous studies have conducted aldehyde measurement in indoor environments. Therefore, we investigated the relationship between exposure to other aldehydes and potential adverse health effects associated with pulmonary toxicity. Epigenetic studies are important for examining the association between environmental exposure and health outcomes and have been utilized for exposure assessment. However, few studies have investigated the association between environmental factors including aldehydes and genome-wide epigenome in humans. Therefore, we focused on epigenetic alterations of saturated aliphatic aldehydes and aldehyde-specific DNA methylation changes as potential biomarkers.
We analysed the DNA methylation patterns of the seven saturated aliphatic aldehydes from propanal (C3) to nonanal (C9) in A549 cells. To identify the critical DNA methylation-based biomarkers of aldehydes, we investigated the correlation between DNA methylation profiles and mRNA expression using microarrays. Microarray technology is a powerful tool for evaluating environmental chemicals on human health, providing valuable genomic information for identifying biomarkers related to occupational exposure and disease prognosis [17] [18] [19] .
Using a DNA methylation array, we identified methylated genes specific for each aldehyde as well as commonly methylated genes among the seven aldehydes at the IC 20 , which shows low cytotoxicity and is useful for identifying genes. A total of 54 genes were commonly methylated compared to in control cells, with a greater than 3.0-fold change cut-off and p-value < 0.05. These methylation alterations were considered as important potential epigenetic-based biomarkers, which can be used to assess cases of aldehyde exposure and predict pulmonary toxicity induced by aldehyde exposure.
Aberrant DNA methylation has been associated with numerous human diseases, cancer, and environmental exposure [20] [21] [22] . Furthermore, hyper/hypo-methylated genes can modify the function of genes and regulate gene expression. Generally, DNA hypermethylation leads to down-regulation of genes and hypomethylation allows for up-regulation of genes. The inverse correlation between DNA methylation and mRNA expression plays critical roles and can serve as potential epigenetic biomarkers. Therefore, we also investigated the correlation between DNA methylation and mRNA expression to identify critical epigenetic biomarkers of aldehydes. In each aldehyde exposure group, we identified numerous anti-correlated methylated genes (Table 4 ). To further investigate the biological relevance of these genes, we performed functional analyses such as GO and KEGG pathway analyses using the DAVID bioinformatics tool (https://david.ncifcrf.gov/). Furthermore, GO terms and KEGG pathways are important indicators for elucidating the biological functions of genes 23 .
First, GO analysis showed that aldehyde-associated epigenetic biomarkers were associated with cell surface receptor-linked signal transduction, cell adhesion, inflammatory response, neurological system process, apoptosis, and Table 3 . Commonly methylated genes of seven aldehydes exposed-A549 cell compared to vehicle control with 3.0-fold change and p-value < 0.05.
SCIEnTIfIC REPORTS | (2018) 8:10497 | DOI:10.1038/s41598-018-28813-z the GPCR signalling pathway. Among the biological processes, cell surface receptor-linked signal transduction and the GPCR signalling pathway were mainly involved in biological processes related to aldehyde exposure. Further studies are needed to determine the molecular mechanisms involved in the effects of aldehyde exposure on the GPCR signalling pathway. Next, we conducted KEGG pathway analysis to identify detailed information on the key biological pathways relevant to aldehyde exposure. The calcium signalling pathway, MAPK signalling pathway, and cancer pathways were linked to the biological significance of aldehydes (Table 5 ). Among the related biological pathways, we previously demonstrated that exposure to butanal and octanal induced MAPK cascades in A549 cells 24, 25 . The MAPK cascades are central signalling pathways in cellular processes that mediate a variety of physiological and pathological functions 26 . Therefore, further studies are required to determine whether aldehydes induce cellular metabolism via MAPK cascades. Taken together, these findings demonstrate that DNA methylation-based epigenetic biomarkers of aldehydes in the human respiratory system can be used for exposure assessment and predicting pulmonary toxicity. Our results also improve the understanding of the underlying mechanisms of aldehyde exposure, which may be useful for determining the developmental toxicological mechanisms of aldehyde-induced environmental lung disease.
Materials and Methods
Chemicals and reagents. Aldehydes Cell culture. The human lung adenocarcinoma epithelial cell line (A549) was obtained from the Korea Cell Line Bank (Seoul, Korea) and grown in RPMI1640(Gibco) supplemented with 10% foetal bovine serum, sodium bicarbonate, HEPES, and penicillin under a humidified atmosphere of 5% CO 2 and 95% air at 37 °C. The culture medium was replaced every 2 or 3 days.
Chemical treatment. A549 cells were treated with each chemical compound at 1.0% of final solvent (DMSO) concentration in multi-well plates. Because of the volatility of the compounds, the plates were sealed with sealing films after chemical treatment. A549 cells were seeded into a 24-well plate at a density of 7.0 × 10 4 cells/mL per well in 500 μL of media for the cytotoxicity assay and seeded into a 6-well plate at a density of 25.0 × 10 4 cells/mL for RNA and genomic DNA extraction. After incubation for 24 h, the cells were treated with the seven aldehydes for 48 h.
Determination of cell viability.
To determine the cell viability and cytotoxic effects of the aldehydes, an MTT cell proliferation assay was performed as described previously by Mosmann 27 .
GO Annotation (Biological process; BP) Preparation of genomic DNA. Genomic DNA was extracted from A549 cells exposed to the seven aldehydes using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) according to manufacturer's instructions. The amount of each genomic DNA was measured using a NanoDrop ND 1000 spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE, USA). Only clear samples without a substantial smear were considered suitable for use and their quality was checked by electrophoresis in a 1.5% agarose gel in 1X TAE buffer (4.8 g of Tris, 1.14 mL of acetic acid, 2 mL of 0.5 M EDTA at pH 8.0, and ethidium bromide) at a constant 100 V for 15 min.
Fragmentation of genomic DNA. Genomic DNA was randomly fragmented using a Sonic Dismembrator 550 (Fisher Scientific, USA) as described previously by Song et al. 28 . Briefly, 5 μg of DNA in 0.2 mL was placed into 1.5-mL tubes immersed in ice and sonicated for various times (10, 20, and 40 s) with a model Sonic Dismembrator 550 (Fischer Scientific, USA) set at 30 W, 1/8-inch horn, and 5% maximum output placed in the centre of the DNA solution at a depth of 5 mm. The size range of the fragmented DNA was evaluated by agarose gel electrophoresis and ethidium bromide staining using DNA size markers 500-10,000 base pairs in size.
Immunoprecipitation of methylated DNA (MeDIP). MeDIP was performed using the MethylMiner
Methylated DNA Enrichment Kit (Invitrogen, Carlsbad, CA, USA) following the manufacturer's instructions. One microgram of fragmented DNA and 3 μg of untreated control DNA (Input) were used for downstream quality procedures and labelling. First, 7 μL of MBD-Biotin Protein was coupled to 10 μL of Dynabeads M-280 Streptavidin according to the manufacturer's instructions. The MBD-magnetic bead conjugates were washed three times and resuspended in 1 volume of 1X bind/ wash buffer. The capture reaction was conducted by adding of 1 μg sonicated DNA to the MBD magnetic beads on a rotating mixer for 1 h at room temperature (RT). All capture reactions were performed in duplicate. Next, the beads were washed three times with 1X bind/wash buffer. The methylated DNA was eluted as a single fraction with a high-salt elution buffer (2,000 mM NaCl). Subsequently, each fraction was concentrated by ethanol precipitation using 1 μL glycogen (20 μg/μL), 1/10th volume of 3 M sodium acetate (pH 5.2), and two volumes of 100% ethanol, and then resuspended in 60 μL of DNase-free water. The eluted MeDIP pellet was stored at −20 °C for long-term storage. Whole genome amplification (WGA). After purification and quantification, MeDIP and Input DNA were amplified using the GenomePlex ® Complete Whole Genome Amplification (WGA2) Kit (Sigma-Aldrich) according to the modified manufacturer's instructions. Two points were modified from the supplier's recommendations: first, the initial DNA fragmentation step was omitted because sonicated DNA was used. Second, 20 ng of IP and Input DNA were used rather than 10 ng. The reactions were cleaned by purification with a column-based technique (QIAquick PCR cleanup columns, Qiagen). Each amplified DNA was quantified using the NanoDrop ND 1000 spectrophotometer. The quality and success of WGA were assessed by agarose gel electrophoresis to evaluate the conservation of size distribution after WGA.
Analysis of promoter DNA methylation and gene expression profile. DNA methylation analysis was conducted on the WGA samples using the Human promoter 2 × 400 K methylation array (Agilent Technologies, Santa Clara, CA, USA). Briefly, 1 μg of amplified DNA and methylated IP samples were annealed with 5 μL of random primer for 3 min at 95 °C and then placed on ice for 5 min. WGA samples were labelled with Cy5 (red) for fully methylated DNA or Cy3 (green) for fragmented DNA using a randomly primed Klenow polymerase reaction using the Agilent Genomic DNA Enzymatic Labeling Kit (Agilent Technologies) according to the manufacturer's instructions. After purification, labelled samples were resuspended with blocking reagent and hybridization buffer, followed by boiling for 3 min at 95 °C and incubated for 30 min at 37 °C, and then hybridized to arrays for 40 h at 67 °C while rotating at 800 RPM in a hybridization oven for 3 min. After washing, the slide was dried and hybridization images on the slides were scanned by the Agilent C scanner and analysed using Agilent Feature Extraction software (v10.7.3.1). All data normalization and selection of fold-changed probes were performed using GeneSpringGX 7.3 (Agilent Technologies). Probes showing a greater than 3.0-fold difference in the ratio between the test and control samples were selected and considered as differentially methylated probes. Gene expression profiling of A549 cells exposed to aldehydes was conducted using the 44 k Whole Human Genome Microarray (Agilent Technologies) as described previously by Song et al. 25 . The data were normalized by dividing the average normalized treated signal intensity by the average normalized control intensity.
